NIROGACESTAT | NIROGACESTAT | ANTINEOPLASTIC GAMMA SECRETASE INHIBITOR TREATMENT OF PROGRESSING DESMOID TUMORS BLOCKS PROTEOLYTIC ACTIVATION OF THE NOTCH RECEPTOR | ORAL | Cmax 1.03 MICROMOLAR Tmax 1.5 HOUR F 19 PERCENT VD 1430 LITER PPB 99.6 PERCENT Cl 45 LITER / HOUR HT 23 HOUR SOLUBILITY SIGNIFICANTLY DECREASES AT PH HIGHER THAN 6.0 | GAMMA SECRETASE | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |